Trident Preclinical Trials
The TRanslational Initiative to DE-risk NeuroTherapeutics (TRIDENT) is revolutionizing preclinical trials for the treatments of neurodegenerative diseases with a $24M grant from the Government of Canada's New Frontiers In Research program. TRIDENT leverages innovative cognition testing, advanced molecular and imaging techniques, and existing industry and academic partnerships to identify and predict highly successful drug candidates. By transforming the nature of preclinical evaluation, our platform will radically improve our ability to identify disease-modifying therapies leading to a world without brain disease.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
5
11 to 50 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Trident Preclinical Trials
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Trident Preclinical Trials
4 distinct titles indexed · top 4 shown.
- 1adminstrative officer
- 1director of operations
- 1research program director
- 1research technician - microscopy
Sign up to unlock all 4 contacts at Trident Preclinical Trials
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Trident Preclinical Trials
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.